Odyssey Investment Partners backed-TrialCard completed the acquisition of Triangle Insights Group.

Odyssey Investment Partners backed-TrialCard, a full-service life sciences commercialization company that provides comprehensive solutions that span the entire biopharmaceutical value chain, completed the acquisition of Triangle Insights Group, a premier strategy consulting firm providing guidance on critical business issues to life science industry leaders. Financial terms were not disclosed. "The addition of Triangle Insights Group to the TrialCard platform is a huge win for the life sciences industry and patients in general. Commercialization and operational considerations are becoming increasingly important during the early pre-approval stages of a product's lifecycle. Our blended team of experts will be well-positioned to provide both the strategic insights and executional excellence to successfully launch and commercialize new products," Scott Dulitz, TrialCard President and Chief Strategy Officer.